The Patent Finder

Immunicom, Inc.

5 patents currently held · Updated Nov 22, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
May 2039
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due May 14, 2027
    The maintenance fee for Increasing Responses to Checkpoint Inhibitors by Extracorporeal Apheresis (US 11,814,430) comes due May 14, 2027. Unpaid by Nov 15, 2027, it lapses early.
  • 1 fee due Oct 16, 2027
    The maintenance fee for Modified TNF as a Capture Ligand (US 11,957,825) comes due Oct 16, 2027. Unpaid by Apr 17, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 5 of 5

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,814,430Increasing Responses to Checkpoint Inhibitors by Extracorporeal Apheresis
In force
 · Medium confidence
In forceMedium confidence
US 11,123,467System and Method for Removal of Immune Inhibitors from Biological Fluids
In force (reinstated)
 · High confidence
In force (reinstated)High confidence
US 11,224,858Reduced Leaching of a Ligand
In force (reinstated)
 · High confidence
In force (reinstated)High confidence
US 11,458,236Reduced Leaching of a Ligand
In force
 · Medium confidence
In forceMedium confidence
US 11,957,825Modified TNF as a Capture Ligand
In force
 · High confidence
In forceHigh confidence

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 pending · 7 abandoned · 11 no status recorded

Showing 1 to 10 of 20, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
18/607,187Modified TNF as a Capture LigandMar 15, 2024Abandoned
18/377,669Increasing Responses to Checkpoint Inhibitors by Extracorporeal ApheresisOct 6, 2023Pending
17/884,387Reduced Leaching of a LigandAug 9, 2022Abandoned
17/824,867May 25, 2022No status recorded
17/737,341May 5, 2022No status recorded
17/730,149Augmentation of Personalized Tumor Specific Adaptive Immunity Through Extracorporeal Removal of Immune Blocking FactorsApr 26, 2022Pending
17/577,248Reduced Leaching of a LigandJan 17, 2022Abandoned
17/519,494Nov 4, 2021No status recorded
17/519,479Nov 4, 2021No status recorded
17/519,462System and Method for Removal of Immune Inhibitors from Biological FluidsNov 4, 2021Abandoned
10 of 20 applications shown.
Pro members see all 20 published applications.
Pro members: see all 20 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited